Skip to main content
Clinical Trials/DRKS00034125
DRKS00034125
Completed
Not Applicable

Inne MINILAB Effectiveness Study for Contraceptive Use

Feral GmbH0 sites300 target enrollmentStarted: May 6, 2024Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Feral GmbH
Enrollment
300

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
Female

Inclusion Criteria

  • I1\) Healthy menstruating women, with previous average menstrual cycle lengths of 22 to 35 days inclusive during the past three cycles,
  • I2\) Living in Germany
  • I3\) Over 18 years old
  • I4\) Women using an iPhone 5S or newer, with a Wireless Fidelity (Wi\-Fi) connection of at least 2\.4 GhZ.
  • I5\) Women agreeing to have regular heterosexual intercourse during the duration of the study (at least once per cycle).
  • I6\) Women agree to not use any form of contraception during their infertile days, and must use one of the following contraceptive methods during their fertile window: abstinence, condom, or diaphragm.
  • I7\) Women accept that there is a risk of unintended pregnancy associated with this study and are in this case intending to carry the pregnancy to term.

Exclusion Criteria

  • E1\) Women currently undergoing or having recently undergone hormonal treatment such as hormonal contraception (including oral, progesterone\-only and combined hormonal methods, or any other hormonal contraceptive program), fertility treatments, or hormone replacement therapy. Since stopping the treatment, the subject has not yet had 3 regular menstrual cycles. An exception to this is hormonal emergency contraception (morning after\-pill).
  • E2\) Women currently using intrauterine copper devices. Since stopping the treatment, the subject has not yet had 1 regular menstrual cycle.
  • E3\) Women currently undergoing or having recently undergone a treatment which may affect her menstrual cycle (this would be mentioned in the patient information leaflet of the treatment, e.g. certain antipsychotics like risperidone, or chemotherapeutic drugs like methotrexate).
  • E4\) Women currently pregnant or who have recently been pregnant (until after the third consecutive period, even if the pregnancy was not carried to term).
  • E5\) Women with known polycystic ovary syndrome or known endometriosis.
  • E6\) Women currently breastfeeding. Women who stopped breastfeeding but did not yet have 3 regular menstrual cycles.
  • E7\) This study is testing the inne MINILAB as a form of contraception. Like all contraception, there is a risk of pregnancy. Women who are not OK with any risk of pregnancy.
  • E8\) Women who have had or have menopausal symptoms such as hot flashes or night sweats.
  • E9\) Women with diagnosed infertility or with an infertile partner, including history of surgical sterilization.
  • E10\) Participation in another clinical trial.

Investigators

Sponsor
Feral GmbH

Similar Trials